![](/img/cover-not-exists.png)
Clinical outcomes of post-remission therapy using90yttrium ibritumomab tiuxetan (Zevalin®) for high-risk patients with diffuse large B-cell lymphoma
Eun Ji Han, Sung-Eun Lee, Sung Hoon Kim, Hyung Sun Sohn, Seung Eun Jung, Gyeongsin Park, Byung-Ock Choi, Sang-Nam Lee, Suk-Woo Yang, Kyungja Han, Seok-Goo ChoVolume:
90
Language:
english
Pages:
8
DOI:
10.1007/s00277-011-1191-6
Date:
September, 2011
File:
PDF, 313 KB
english, 2011